| NPCR/SEER |
2001–2015 Database (PCa) |
31 clinical parameters, such as age, race, grade, diagnostic confirmation and laterality |
– |
– |
3,086,534 |
| NPCR/SEER |
2005–2015 Database (PCa) |
25 clinical parameters, such as age, race, grade, diagnostic confirmation and laterality |
– |
– |
2,294,444 |
| SEER |
YR1973_2015.SEER9 (PCa) |
133 clinical parameters, such as age, race, Gleason scores, TNM stages, PSA values, survival data and therapy data |
– |
– |
637,005 |
| SEER |
YR2000_2015.CA_KY_LO_NJ_GA (PCa) |
133 clinical parameters, such as age, race, Gleason scores, TNM stages, PSA values, survival data and therapy data |
– |
– |
461,552 |
| SEER |
YR1992_2015.SJ_LA_RG_AK (PCa) |
133 clinical parameters, such as age, race, Gleason scores, TNM stages, PSA values, survival data and therapy data |
– |
– |
164,576 |
| PLCO |
Prostate |
Data for PCa screening, incidence, and mortality analyses |
– |
– |
76,682 |
| PLCO |
Prostate Screening |
Additional information from PSA and DRE cancer screens |
– |
– |
35,875 |
| PLCO |
Prostate Diagnostic Procedures |
Information about the diagnostic procedures prompted by positive PCa screens |
– |
– |
15,307 |
| PLCO |
Prostate Treatments |
Specifics of the initial treatment following the diagnosis of PCa |
– |
– |
7,614 |
| PLCO |
Prostate Screening Abnormalities |
Information for each induration found during the DRE screen |
– |
– |
5,743 |
| PLCO |
Prostate Medical Complications |
Information about the medical complications caused by diagnostic workup for PCa |
– |
– |
2,164 |
| cBioPortal/Synapse |
GENIE |
13 clinical parameters, such as age, race and ethnicity |
Mutation data |
– |
2,008 |
| SEER |
YR2005.LO_2ND_HALF (PCa) |
133 clinical parameters, such as age, race, Gleason scores, TNM stages, PSA values, survival data and therapy data |
– |
– |
1,352 |
| cBioPortal |
Prostate Adenocarcinoma (MSKCC/DFCI) |
19 clinical parameters, such as cancer type, diagnosis age and Gleason scores |
Mutation data and copy number alteration data |
– |
1,013 |
| cBioPortal/ICGC/GDC/TCIA |
Prostate Adenocarcinoma (TCGA, Provisional), aka PRAD-US |
100 clinical parameters, such as Gleason scores, TNM values, survival data, age, weight, ethnicity, PSA values and MRI results |
Mutation data and copy number alteration data |
16,790 CT, PT, MR images in 207 series from 14 patients. 3.74 GB of data. Tissue slide images included |
498 |
| cBioPortal |
Prostate adenocarcinoma (TCGA, PanCancer Atlas) |
83 clinical parameters, such as diagnosis age, cancer type, ethnicity category, patient weight and race category |
Mutation data and copy number alteration data |
– |
494 |
| cBioPortal |
Genomic Hallmarks of Prostate Adenocarcinoma (CPC-GENE) |
89 clinical parameters, such as Gleason scores, PSA values, weight, survival data, TNM stages and MRI results |
Comprehensive genomic profiling of 477 Prostate Adenocarcinoma samples from CPC-GENE and public data sets, including TCGA-PRAD |
– |
477 |
| cBioPortal |
MSK-IMPACT Clinical Sequencing Cohort (MSKCC): Prostate Cancer |
17 clinical parameters, such as clinical Gleason, age and mutation data |
Targeted sequencing of clinical cases via MSK-IMPACT for PCa |
– |
451 |
| TCIA |
PROSTATEx Challenge |
– |
– |
309,251 MR (T2W, PD-W, DCE and DW) images, 15.1 GB of data |
346 |
| cBioPortal |
Prostate Adenocarcinoma (TCGA) |
89 clinical parameters, such as clinical and reviewed Gleason scores, age and gene mutation data |
Integrated profiling of 333 primary prostate adenocarcinoma samples |
– |
333 |
| cBioPortal |
Prostate Adenocarcinoma (MSKCC) |
25 clinical parameters, such as radical prostatectomy Gleason scores, survival data, tumor stages and ERG Fusion data |
181 primary, 37 metastatic PCa samples, 12 PCa cell lines and xenografts |
– |
216 |
| ICGC |
PRAD-UK: Prostate Adenocarcinoma - United Kingdom |
6 files with clinical data: donor, donor exposure, donor family, donor therapy, sample and specimen |
Simple Somatic Mutations (SSM) for 215 patients. Copy Number Somatic Mutations (CNSM) for 13 patients. Structural Somatic Mutations (StSM) for 13 patients |
– |
216 |
| ICGC |
EOPC-DE: Early Onset Prostate Cancer - Germany |
6 files with clinical data: donor, donor exposure, donor family, donor therapy, sample and specimen |
Simple Somatic Mutations (SSM) for 202 patients. Copy Number Somatic Mutations (CNSM) for 11 patients. Structural Somatic Mutations (StSM) for 11 patients |
– |
211 |
| cBioPortal |
Metastatic Prostate Cancer, SU2C/PCF Dream Team |
20 clinical parameters, such as age and prior medications |
Comprehensive analysis of 150 metastatic PCa samples |
– |
150 |
| ICGC |
PRAD-CA: Prostate Adenocarcinoma - Canada |
6 files with clinical data: donor, donor exposure, donor family, donor therapy, sample and specimen |
SSM data for 124 patients. CNSM data for 125 patients. StSM data for 123 patients. SGV data for 123 patients. METH-A data for 102 patients |
– |
125 |
| cBioPortal |
Prostate Adenocarcinoma (Broad/Cornell 2012) |
15 clinical parameters, such as Gleason score 4–5%, age, PSA values, radical prostatectomy Gleason scores and modified Capra S Scores |
Comprehensive profiling of 112 PCa samples |
– |
112 |
| cBioPortal |
Prostate Adenocarcinoma CNA study (MSKCC) |
37 clinical parameters, such as biopsy and pathology Gleason scores, survival data, PSA values, age, extracapsular extension and treatment data |
Copy-number profiling of 103 primary PCa samples from MSKCC |
– |
104 |
| R ElemStatLearn package |
Prostate (R) |
9 clinical parameters: cancer volume, prostate weight, age, amount of benign prostatic hyperplasia, seminal vesicle invasion, capsular penetration, Gleason scores, percent of Gleason score 4 or 5 and PSA values |
– |
– |
97 |
| TCIA |
Prostate-Diagnosis |
4 clinical text fields: path report biopsy, path prostate specimen, MRI report, treatment |
– |
32,537 MR images (T1, T2, and DCE sequences) in 368 series, 5.6 GB of data. 3D segmentation files included |
92 |
| cBioPortal |
Neuroendocrine Prostate Cancer (Trento/Cornell/Broad) |
16 clinical parameters, such as genomic burden, pathology classification and ploidy |
Whole exome and RNA Seq data of castration resistant adenocarcinoma and castration resistant neuroendocrine PCa (somatic mutations and copy number aberrations) |
– |
81 |
| cBioPortal/ICGC |
Prostate Adenocarcinoma (Sun Lab), aka PRAD-CN |
20 clinical parameters, such as cancer type, diagnosis age, PSA values, Gleason scores and TNM stage |
Mutation data and copy number alteration data |
– |
65 |
| TCIA |
Prostate-3T |
– |
– |
1,258 MR (T2W) images in 64 series, 284 MB of data. Files with segmentation data included |
64 |
| cBioPortal |
Prostate Adenocarcinoma (Fred Hutchinson CRC) |
26 clinical parameters, such as chemotherapy data, EXOME data, number of tumors and PSA values |
Comprehensive profiling of 176 PCa samples |
– |
63 |
| cBioPortal |
Metastatic Prostate Adenocarcinoma (MCTP) |
26 clinical parameters, such as therapy info, PSA values, Gleason scores and survival data |
Comprehensive profiling of 50 metastatic CRPCs and 11 high-grade localized PCa |
– |
59 |
| cBioPortal |
Prostate Adenocarcinoma (Broad/Cornell 2013) |
20 clinical parameters, such as Gleason score 4–5%, age, PSA values, radical prostatectomy Gleason scores and tumor stages |
Comprehensive profiling of 57 PCa samples |
– |
57 |
| TCIA |
Prostate Fused-MRI-Pathology |
– |
– |
32,508 MR images in 325 series, 4.4 GB of data. Annotated whole slide pathology images and fused Rad-Path Matlab files included |
28 |
| TCIA |
Prostate-MRI |
– |
– |
22,036 MR (with some PET/CT) images in 182 series, 3.2 GB of data. Pathology images included |
26 |
| ICGC |
PRAD-FR: Prostate Adenocarcinoma-France |
6 files with clinical data: donor, donor family, donor surgery, sample and specimen |
SSM data, CNSM data, StSM data, SGV data |
– |
25 |
| TCIA |
QIN PROSTATE |
– |
– |
25,981 MR images in 319 series, 4.4 GB of data |
22 |
| TCIA |
QIN-PROSTATE-Repeatability |
– |
– |
2,504 MR images in 270 series, 1.1 GB of data. Manual segmentations and volume measurements included |
15 |
| TCIA |
NaF Prostate |
– |
– |
64,535 PET/CT images, 12.9 GB of data. DICOM metadata digest included |
9 |
| cBioPortal |
Prostate Adenocarcinoma Organoids (MSKCC) |
18 clinical parameters, such as PSA values, HGB values, ALP values, LDH values and therapy info |
Exome profiling of PCa samples and matched organoids |
– |
7 |
| GEO |
51 datasets, see Table S1
|
– |
see Table S1
|
– |
see Table S1
|
| ArrayExpress |
126 datasets, see Table S2
|
– |
see Table S2
|
– |
see Table S2
|
